ÂÜÀòÂÒÂ×

David Z Gil is a seasoned professional in clinical affairs with extensive experience in project and portfolio management across multiple healthcare organizations. Currently serving as Senior Director of Clinical Affairs at Dexcom since January 2022, David previously held senior roles at Gilead Sciences and Elixir Medical Corporation. David's tenure at Abbott from March 2007 to March 2020 included leadership positions overseeing global clinical programs, managing large teams and budgets, and directing clinical operations for various business units, while successfully integrating clinical affairs after significant mergers. David's earlier experience includes roles at BioMarin Pharmaceutical and Quintiles, demonstrating a consistent track record of overseeing clinical trials, ensuring compliance with operational targets, and implementing strategic processes in diverse therapeutic areas. David holds a Bachelor of Science in Health Care Administration/Management from the University of Wisconsin-Madison.